Mechanism-based engineering against anthracycline cardiotoxicity.
Publication
, Journal Article
Force, T; Wang, Y
Published in: Circulation
July 9, 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 9, 2013
Volume
128
Issue
2
Start / End Page
98 / 100
Location
United States
Related Subject Headings
- Neuregulin-1
- Myocytes, Cardiac
- Male
- Humans
- Female
- Doxorubicin
- Chemical Engineering
- Cardiovascular System & Hematology
- Cardiotonic Agents
- Animals
Citation
APA
Chicago
ICMJE
MLA
NLM
Force, T., & Wang, Y. (2013). Mechanism-based engineering against anthracycline cardiotoxicity. Circulation, 128(2), 98–100. https://doi.org/10.1161/CIRCULATIONAHA.113.003688
Force, Thomas, and Yibin Wang. “Mechanism-based engineering against anthracycline cardiotoxicity.” Circulation 128, no. 2 (July 9, 2013): 98–100. https://doi.org/10.1161/CIRCULATIONAHA.113.003688.
Force T, Wang Y. Mechanism-based engineering against anthracycline cardiotoxicity. Circulation. 2013 Jul 9;128(2):98–100.
Force, Thomas, and Yibin Wang. “Mechanism-based engineering against anthracycline cardiotoxicity.” Circulation, vol. 128, no. 2, July 2013, pp. 98–100. Pubmed, doi:10.1161/CIRCULATIONAHA.113.003688.
Force T, Wang Y. Mechanism-based engineering against anthracycline cardiotoxicity. Circulation. 2013 Jul 9;128(2):98–100.
Published In
Circulation
DOI
EISSN
1524-4539
Publication Date
July 9, 2013
Volume
128
Issue
2
Start / End Page
98 / 100
Location
United States
Related Subject Headings
- Neuregulin-1
- Myocytes, Cardiac
- Male
- Humans
- Female
- Doxorubicin
- Chemical Engineering
- Cardiovascular System & Hematology
- Cardiotonic Agents
- Animals